28th Annual Meeting Society for Immunotherapy of Cancer

The SITC 28th Annual Meeting provides a multidisciplinary educational and interactive environment focused on improving the outcome for current and future patients with cancer by incorporating strategies based on basic and applied cancer immunotherapy. The meeting consists of cutting-edge research presentations by experts in the field, both oral and poster abstract presentations and ample opportunity for structured and informal discussions, including important networking opportunities. In addition, the meeting includes updates on major national and international initiatives coming from academia, government and industry, as well as important society projects.

Session Topics
• Adoptive Immunotherapy
• Antibody Recognition to Mobilize Cells Of The Innate and Adaptive Immune Systems (Antibody Dependent Cell-Mediated Cytotoxicity: ADCC
• Biomarkers and Immunoscoring
• Combination Approach In Cancer
• Metabolism and Immunity
• Tumor Immune Resistance and Overcoming it
• Tumor Microenvironment and Innate Cells Recognition
• Vaccines

The SITC 28th Annual Meeting is a part of SITC 2013. This five-day event offers the latest, most relevant research, educational sessions, and networking opportunities in a variety of formats, including the SITC Workshop on Personalized Cancer Immunotherapy which will take place on November 7, and the SITC Primer on Tumor Immunology and Cancer Immunotherapy™ which will also take place on November 7. Abstract submission, registration and housing for SITC 2013 will open May 1 on the SITC 2013 meeting website - www.sitcancer.org/2013





+ show speakers and program
Organizers
• Paolo Antonio Ascierto, MD - Instituto Nazionale Tumori-Fondazione ‘G. Pascale’
• David H. Munn, MD - Georgia Regents University
• A. Karolina Palucka, MD, PhD - Baylor Institute for Immunology Research
• Paul M. Sondel, MD, PhD - University of Wisconsin


8 Nov - 10 Nov 2013

National Harbor
United States of America
meeting website